Key result
Citrus flavonoids are linked to improved cardiometabolic outcomes via reduced oxidative stress and inflammation.
The prevalence of cardiovascular disease (CVD) is increasing over time. CVD is a comorbidity in diabetes and contributes to premature death. Citrus flavonoids possess several biological activities and have emerged as efficient therapeutics for the treatment of CVD. Citrus flavonoids scavenge free radicals, improve glucose tolerance and insulin sensitivity, modulate lipid metabolism and adipocyte differentiation, suppress inflammation and apoptosis, and improve endothelial dysfunction. The intake of citrus flavonoids has been associated with improved cardiovascular outcomes. Although citrus flavonoids exerted multiple beneficial effects, their mechanisms of action are not completely established. In this review, we summarized recent findings and advances in understanding the mechanisms underlying the protective effects of citrus flavonoids against oxidative stress, inflammation, diabetes, dyslipidemia, endothelial dysfunction, and atherosclerosis. Further studies and clinical trials to assess the efficacy and to explore the underlying mechanism(s) of action of citrus flavonoids are recommended.
No takes yet. Share an insight, caveat, or question.
Mahmoud et al. (2019) conducted a review in Cardiovascular disease and metabolic disorders. Citrus flavonoids was evaluated. Citrus flavonoids are associated with improved cardiovascular and metabolic outcomes through protective effects against oxidative stress, inflammation, diabetes, dyslipidemia, and atherosclerosis.
Synapse has enriched 5 related papers. Consider them for comparative context: